Price $107.59 |
Market Cap
15.15B
|
Sector Health Care |
Div. Growth
8.80%
|
|
P/E
22.3
|
P/B
2.86
|
P/S
1.95
|
Dividend %
1.80%
|
|
P/CF
-
|
P/FCF
23.3
|
Op. Cash Flow
1.19M
|
FCF
4.7
|
|
Op. Margin
14.90%
|
Net Margin
10.50%
|
ROE
16.20%
|
ROI
9.30%
|
|
ROA
7.60%
|
EPS Growth
16.10%
|
Current Ratio
1.2
|
Debt/Equity
76.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vaxart Inc (VXRT) | $3.03 | - | - | 21.9M | Strong Buy |
| IRIDEX Corporation (IRIX) | $6.51 | - | - | 101.8M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.40 | - | - | 62.1M | Strong Buy |
| Imprimis Pharmaceuticals Inc (IMMY) | $2.79 | - | - | 65.5M | Strong Buy |
| ImmuCell Corporation (ICCC) | $8.84 | - | - | 37.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
